Combination therapy of patients with cancer of the osphagus and stomach
Chernousov, A.F.; Stranadko, E.F.; Ankudinov, V.A.; Zverev, M.P.; Karlashenko, N.I.
Voprosy Onkologii 25(12): 50-53
1979
ISSN/ISBN: 0507-3758 PMID: 516584 Document Number: 147823
Experience with the treatment of 139 patients with cancer of the esophagus and stomach indicated that preoperative irradiation (3000-4500 rad) considerably improves late results of the treatment.
Document emailed within 1 workday
Related Documents
Chernyĭ, V.A.; Korobko, V.B.; Shchepotin, I.B.; Maligonov, P.A. 1989: Combination treatment of cancer of the stomach using preoperative telegammatherapy in combination with local SHF-hyperthermia Klinicheskaia Khirurgiia 5: 31-32Böttcher, K.; Siewert, J.R.; Roder, J.D.; Busch, R.; Hermanek, P.; Meyer, H.J. 1994: Risk of surgical therapy of stomach cancer in Germany. Results of the German 1992 Stomach Cancer Study. German Stomach Cancer Study Group ('92) Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 65(4): 298-306
Hioki, M.; Kagawa, S.; Fujiwara, T.; Sakai, R.; Kojima, T.; Watanabe, Y.; Hashimoto, Y.; Uno, F.; Tanaka, N.; Fujiwara, T. 2008: Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy International Journal of Cancer 122(11): 2628-2633
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62
Zhivetskiĭ, A.V.; Bodnar, G.V. 1984: Chronopharmacological basis for the therapy of water-salt imbalance in patients with stomach cancer Voprosy Onkologii 30(7): 75-80
Manziuk, L.V.; Komov, D.V.; Khaĭlenko, V.A.; Artamonova, E.V.; Mikhina, Z.P.; Ermilova, V.D.; Abashin, S.I. 2001: Combination therapy of patients with locally advanced breast cancer Voprosy Onkologii 47(6): 740-743
Shchepotin, I.B.; Chernyĭ, V.A.; Berdinskikh, N.K.; Sanina, O.L.; Baraboĭ, V.A.; Starosel'skiĭ, I.V.; Korobko, V.B.; Kamenets, L.I.; Iaremenko, L.I. 1991: The use of ceruloplasmin in combination with adjuvant polychemotherapy in stomach cancer Vrachebnoe Delo 3: 24-27
Fukuo, Y.; Terashi, A.; Hayashi, Y.; Yano, Y.; Atarashi, J. 1985: A clinical trial of cis-platinum (II) in combination with PSK and FT-207 in advanced stomach cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(4): 960-965
Kobayashi, M. 1990: Studies on trace elements in cancerous stomach tissue of the patients with stomach cancer Hokkaido Journal of Medical Science 65(3): 320-335
Menichetti, F.; Bucaneve, G.; Patoia, L.; Guerciolini, R.; Minotti, V.; Pauluzzi, S.; Del Favero, A. 1987: Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 403-405
Fram, R.; Skarin, A.; Balikian, J.; Amato, D.; Leslie, N.; Malcolm, A.; Frei, E. 1985: Combination chemotherapy followed by radiation therapy in patients with regional stage IIi unresectable non-small cell lung cancer Cancer Treatment Reports 69(6): 587-590
Hibi, S.; Ina, K.; Furuta, R.; Kataoka, T.; Kojima, S.; Kawai, M. 2009: Clinical effects of Hange-shashin-to on combination therapy of S-1/irinotecan against the for patients with metastatic gastric and colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1485-1488
Watanabe, N.; Kaneko, T.; Fujitani, S.; Umeyama, M.; Nomura, Y.; Zusho, H.; Yamada, Y.; Nanba, G.; Asahina, N.; Sugio, Y.; Okamoto, Y.; Daida, T.; Tokumaru, T. 1999: A combination of low-dose carboplatin (CBDCA) and radiation therapy in head and neck cancer patients--response and hematologenic toxicity Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(1): 101-106
Sugawara, A.; Munakata, K.; Ishida, T.; Sato, S.; Yoshikawa, M.; Watanabe, K.; Saito, J.; Ohtsuka, Y.; Munakata, M. 2006: A case of advanced double cancer of the lung and stomach responding to combination chemotherapy of cisplatin and TS-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(7): 973-975
Kubota, E.; Kataoka, H.; Hayashi, K.; Kamiya, T.; Sasaki, M.; Ogasawara, N.; Yamada, T.; Wada, T.; Mori, Y.; Mizoshita, T.; Shimura, T.; Mizushima, T.; Okamoto, Y.; Ohara, H.; Joh, T. 2009: Advanced stomach and pancreas cancer successfully treated with combination chemotherapy with S-1/paclitaxel/lentinan Hepato-Gastroenterology 56(89): 106-110
Fujiwara, Y.; Taniguchi, H.; Kimura, Y.; Takiguchi, S.; Yasuda, T.; Yano, M.; Monden, M. 2003: Two advanced gastric cancer patients who showed malignant ileus soon after administration of combination therapy of preoperative intra-peritoneal chemotherapy and gastrectomy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(11): 1614-1617
Sawada, Y.; Fujii, T.; Takahashi, H.; Yokoyama, G.; Matsubayashi, R.N.; Inoue, Y.; Uesugi, N.; Momosaki, S.; Toh, U.; Shirouzu, K. 2009: A case of triple negative chest wall recurrent breast cancer treated with capecitabine and docetaxel combination therapy (XT therapy) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 815-817
Izumi, M.; Iino, Y.; Yokoe, T.; Inoue, T.; Yamada, T.; Kobayashi, I.; Andoh, T.; Yokota, T.; Iijima, T.; Morishita, Y. 1994: Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(2): 265-268
Yang, W.; Chen, J.; Li, W.; Chen, X. 2008: Preventive effects of 4 Se-enriched plants on rat stomach cancer induced by MNNG 2. Safety of different selenium resources for prevention of stomach cancer Wei Sheng Yan Jiu 37(1): 90-92
Watanabe, A.; Taniguchi, M. 2005: A case of oropharyngeal cancer with multiple bone metastases from prostate cancer that responded to docetaxel, ifosfamide and cisplatin combination therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 65-67